On 2025-04-25, Jade Biosciences, Inc. (JBIO) announced earnings per share of $-3.16 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-10.53.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.45 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-04-25 | 2025-03-31 | $-10.53 | $-3.16 |
| 2025-03-27 | 2024-12-31 | $-6.67 | $-6.67 |
| 2024-11-12 | 2024-09-30 | $-20.70 | $-19.65 |
| 2024-08-12 | 2024-06-30 | $-26.67 | $-30.18 |
| 2024-05-13 | 2024-03-31 | $-25.96 | $-29.12 |
| 2024-03-25 | 2023-12-31 | $-23.86 | $-25.96 |
| 2023-11-13 | 2023-09-30 | $-24.56 | $-24.91 |
| 2023-08-14 | 2023-06-30 | $-24.21 | $-26.67 |
| 2023-05-15 | 2023-03-31 | $-20.35 | $-23.51 |
| 2023-03-29 | 2022-12-31 | $-20.35 | $-21.40 |
| 2022-11-14 | 2022-09-30 | $-17.54 | $-19.65 |
| 2022-08-15 | 2022-06-30 | $-16.14 | $-17.19 |
| 2022-05-16 | 2022-03-31 | $-9.12 | $-15.79 |
| 2022-03-30 | 2021-12-31 | -- | $-2.46 |
| 2021-11-15 | 2021-09-30 | $-9.12 | $-9.12 |
| 2021-08-16 | 2021-06-30 | $-5.61 | $-835.09 |